SHOX2 and breast cancer: In the present study, our TCGA data established the connection between SHOX2 abundance and a high gene expression signature of Gene Hallmark EPITHELIAL_MESENCYMAL_TRANSITION in breast cancer patients, providing a strong rationale for targeting SHOX2 in metastatic breast cancer.